Related Experiment Video

Updated: Jul 4, 2026

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue

L J Duerner1, A Schwantes, I C Schneider

  • 1Abteilung Medizinische Biotechnologie, Paul-Ehrlich-Institut, Langen, Germany.

Gene Therapy
|May 30, 2008
PubMed

Insights

Tumor-targeted murine leukemia virus (MLV) variants show significantly improved safety for cancer therapy by selectively infecting tumors. This engineering reduces risks associated with non-targeted MLV, enhancing virotherapy potential.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy

Background:

  • Virotherapy utilizes replication-competent murine leukemia virus (MLV) for cancer treatment.
  • MLV carries a risk of insertional mutagenesis, necessitating safety evaluations.
  • Conditionally replication-competent MLV variants activated by tumor-associated proteases have been developed.

Purpose of the Study:

  • To compare the tumor-targeting and safety profiles of non-targeted and tumor-targeted MLV variants.
  • To assess the biodistribution and infectivity of engineered MLV in vivo.
  • To evaluate the potential of protease-activated MLV for safer clinical application.

Main Methods:

  • Comparative study of non-targeted and tumor-targeted MLV variants in immunodeficient mice.
  • Systemic administration of MLV variants.
  • Quantitative analysis of virus spreading to tumor and extratumoral organs.

Main Results:

  • Both MLV types efficiently infected tumor cells after systemic administration.
  • Non-targeted MLV extensively infected extratumoral organs, including bone marrow, spleen, and liver.
  • Tumor-targeted MLV demonstrated up to 500-fold greater selectivity for tumor tissue infection compared to non-targeted MLV.

Conclusions:

  • Non-targeted MLV poses significant safety concerns for clinical use due to off-target infections.
  • Engineering MLV for activation by tumor-associated proteases substantially enhances its safety profile.
  • Protease-activated MLV variants represent a promising advancement for safer and more effective virotherapy.

More Related Videos

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments09:12

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments

Published on: March 28, 2025

Radial Mobility and Cytotoxic Function of Retroviral Replicating Vector Transduced, Non-adherent Alloresponsive T Lymphocytes10:01

Radial Mobility and Cytotoxic Function of Retroviral Replicating Vector Transduced, Non-adherent Alloresponsive T Lymphocytes

Published on: February 11, 2015

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...